Literature DB >> 16359665

Modulation of the antigen transport machinery TAP by friends and enemies.

Rupert Abele1, Robert Tampé.   

Abstract

The transporter associated with antigen processing (TAP) is a key factor of the major histocompatibility complex (MHC) class I antigen presentation pathway. This ABC transporter translocates peptides derived mainly from proteasomal degradation from the cytosol into the ER lumen for loading onto MHC class I molecules. Manifold mechanisms have evolved to regulate TAP activity. During infection, TAP expression is upregulated by interferon-gamma. Furthermore, the assembly and stability of the transport complex is promoted by various auxiliary factors. However, tumors and viruses have developed sophisticated strategies to escape the immune surveillance by suppressing TAP function. The activity of TAP can be impaired on the transcriptional or translational level, by enhanced degradation or by inhibition of peptide translocation. In this review, we briefly summarize existing data concerning the regulation of the TAP complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16359665     DOI: 10.1016/j.febslet.2005.11.048

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  A proteomics dissection of Arabidopsis thaliana vacuoles isolated from cell culture.

Authors:  Michel Jaquinod; Florent Villiers; Sylvie Kieffer-Jaquinod; Véronique Hugouvieux; Christophe Bruley; Jérôme Garin; Jacques Bourguignon
Journal:  Mol Cell Proteomics       Date:  2006-12-06       Impact factor: 5.911

2.  HMME-based PDT restores expression and function of transporter associated with antigen processing 1 (TAP1) and surface presentation of MHC class I antigen in human glioma.

Authors:  Shan-Yi Zhang; Jun-Liang Li; Xin-Ke Xu; Mei-Guang Zheng; Cheng-Cai Wen; Fang-Cheng Li
Journal:  J Neurooncol       Date:  2011-04-26       Impact factor: 4.130

Review 3.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.

Authors:  Ian Mantel; Barzan A Sadiq; J Magarian Blander
Journal:  Mol Immunol       Date:  2021-12-29       Impact factor: 4.174

Review 4.  Targeted degradation of ABC transporters in health and disease.

Authors:  Daphne Nikles; Robert Tampé
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

5.  Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation.

Authors:  Jennifer M Bomberger; Kenneth H Ely; Naveen Bangia; Siying Ye; Kathy A Green; William R Green; Richard I Enelow; Bruce A Stanton
Journal:  J Biol Chem       Date:  2013-11-18       Impact factor: 5.157

6.  PRED(TAP): a system for prediction of peptide binding to the human transporter associated with antigen processing.

Authors:  Guang Lan Zhang; Nikolai Petrovsky; Chee Keong Kwoh; J Thomas August; Vladimir Brusic
Journal:  Immunome Res       Date:  2006-05-23

7.  The ABC transporter gene family of Daphnia pulex.

Authors:  Armin Sturm; Phil Cunningham; Michael Dean
Journal:  BMC Genomics       Date:  2009-04-21       Impact factor: 3.969

8.  Genome-wide identification, characterization and phylogenetic analysis of 50 catfish ATP-binding cassette (ABC) transporter genes.

Authors:  Shikai Liu; Qi Li; Zhanjiang Liu
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

9.  Rescue of MHC-1 antigen processing machinery by down-regulation in expression of IGF-1 in human glioblastoma cells.

Authors:  Yuexin Pan; Jerzy Trojan; Yajun Guo; Donald D Anthony
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

10.  The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1.

Authors:  Irini Evnouchidou; Frank Momburg; Athanasios Papakyriakou; Angeliki Chroni; Leondios Leondiadis; Shih-Chung Chang; Alfred L Goldberg; Efstratios Stratikos
Journal:  PLoS One       Date:  2008-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.